Frank Struyf
0000-0001-9988-0260
Publication & Citation Trends
Publications
0 total
Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial OA
Cited by 2
Semantic Scholar
Comparison of vaccine-induced immune thrombocytopenia and thrombosis cases following two adenovirus-vectored COVID-19 vaccines
Cited by 3
Semantic Scholar
Reactogenicity, safety, and immunogenicity of a quadrivalent seasonal influenza vaccine in adults aged 65 years and older: Phase 4 study results from India during December 2023–February 2024
Cited by 0
Semantic Scholar
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trial OA
Cited by 3
Semantic Scholar
Safety, immunogenicity and pregnancy outcomes in mothers and infants after vaccination with an adenovirus-vector COVID-19 vaccine during pregnancy
Cited by 3
Semantic Scholar
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data
Cited by 3
Semantic Scholar
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial
Cited by 0
Semantic Scholar
Modelling antibody dynamics in humans after different Ad26.COV2.S vaccination schemes
Cited by 0
Semantic Scholar
Research Topics
Cervical Cancer and HPV Research
(78)
Hepatitis B Virus Studies
(63)
Genital Health and Disease
(44)
SARS-CoV-2 and COVID-19 Research
(36)
COVID-19 Clinical Research Studies
(24)
Affiliations
Northwestern University
University of Maryland, Baltimore
Johnson & Johnson (United States)
Janssen (Belgium)
GlaxoSmithKline (United Kingdom)